Sertaconazole API Manufacturers

Looking for Sertaconazole API 99592-32-2?

Description:

Here you will find a list of producers, manufacturers and traders of Sertaconazole. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Sertaconazole 

Synonyms:

Demofix , Ertaczo , Sertaconazol , Sertaconazole , Sertaconazolum , Sertaconazole nitrate  

Cas Number:

99592-32-2 

DrugBank number:

DB01153 

Unique Ingredient Identifier:

72W71I16EG

Sertaconazole is a type of Triazoles

Triazoles are a prominent subcategory of pharmaceutical Active Pharmaceutical Ingredients (APIs) that possess a chemical structure containing a five-membered ring composed of three nitrogen atoms and two carbon atoms. These compounds have gained significant attention in the pharmaceutical industry due to their diverse pharmacological activities and therapeutic applications.

Triazoles exhibit a broad spectrum of biological activities, including antimicrobial, antifungal, antiviral, anticancer, and anti-inflammatory properties. These characteristics make them valuable in the development of new drugs and treatment options for various diseases.

One notable application of triazoles is their role as antifungal agents. Certain triazole-based drugs, such as fluconazole and itraconazole, have proven highly effective in treating fungal infections. They work by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes, thus disrupting their growth and replication.

Triazoles have also demonstrated potential as antiviral agents. Compounds like voriconazole and posaconazole exhibit antiviral activity against certain RNA viruses, including influenza and respiratory syncytial virus (RSV). They function by targeting specific viral enzymes or proteins, preventing viral replication and spread.

In addition to their antifungal and antiviral properties, triazoles have been investigated for their anticancer potential. Some derivatives of triazoles have shown promising results in inhibiting cancer cell growth and inducing apoptosis, making them potential candidates for future cancer therapies.

Overall, the versatile nature of triazoles makes them a promising class of compounds in pharmaceutical research and drug development, offering a wide range of therapeutic possibilities for various medical conditions.

Sertaconazole (Triazoles), classified under Antifungals

Antifungals are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) designed to combat fungal infections. These medications are developed to target and eliminate fungi, including yeasts and molds, which can cause a range of diseases in humans and animals.

Antifungals work by interfering with specific components or processes essential for fungal growth and reproduction. They may inhibit the synthesis of fungal cell walls or disrupt the production of ergosterol, a crucial component of fungal cell membranes. By targeting these key mechanisms, antifungal APIs effectively hinder the growth and spread of fungal infections.

The diversity within the antifungal category is reflected in the various classes of antifungal APIs available. Azoles, polyenes, echinocandins, and allylamines are common classes of antifungals. Each class exhibits unique mechanisms of action and targets specific types of fungi. This diversity enables healthcare professionals to tailor treatment plans to the specific fungal infection, optimizing therapeutic outcomes.

Antifungal APIs find application in various pharmaceutical formulations, including oral medications, topical creams, ointments, and intravenous solutions. They are crucial for the treatment of common fungal infections like athlete's foot, ringworm, vaginal yeast infections, and oral thrush. Additionally, antifungals play a crucial role in managing serious systemic fungal infections that can pose significant health risks, especially in immunocompromised individuals.

Overall, antifungal APIs are indispensable tools in the fight against fungal infections, offering effective treatment options and improving the quality of life for patients suffering from these conditions. With ongoing research and development, the antifungal category continues to evolve, providing innovative solutions to combat the ever-changing landscape of fungal pathogens.

• Inabata France (Pharmasynthèse) from France, product country of origin France
• Optimus Drugs Pvt Ltd from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.